Zobrazeno 1 - 10
of 181
pro vyhledávání: '"Hoet B"'
Autor:
Kong, N.C.T., Beran, J., Kee, S.A., Miguel, J.L., Sánchez, C., Bayas, J.-M., Vilella, A., Calbo-Torrecillas, F., López de Novales, E., Srinivasa, K., Stoffel, M., Hoet, B. *
Publikováno v:
In Kidney International 1 April 2008 73(7):856-862
Publikováno v:
In Travel Medicine and Infectious Disease 2007 5(3):171-175
Publikováno v:
In Transactions of the Royal Society of Tropical Medicine and Hygiene 2007 101(5):465-468
Autor:
Boelaert, F a, *, Deluyker, H b, Maes, D b, Godfroid, J a, Raskin, A c, Varewijck, H c, Pensaert, M b, Nauwynck, H b, Castryck, F d, Miry, C d, Robijns, J.M d, Hoet, B d, Segers, E d, Van Vlaenderen, I a, Robert, A e, Koenen, F a
Publikováno v:
In Preventive Veterinary Medicine 1999 41(4):239-255
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Travel medicine and infectious disease
University of Antwerp
University of Antwerp
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Verstraete M, Nurmohamed M, Kienast J, matthias siebeck, Silling-Engelhardt G, Büller H, Hoet B, Bichler J, Close P
Publikováno v:
Journal of the American College of Cardiology, 22(4), 1080-8. Elsevier USA
Verstraete, M, Nurmohamed, M, Kienast, J, Siebeck, M, Silling-Engelhardt, G, Büller, H, Hoet, B, Bichler, J & Close, P 1993, ' Biologic effects of recombinant hirudin (CGP 39393) in human volunteers. European Hirudin in Thrombosis Group ', Journal of the American College of Cardiology, vol. 22, no. 4, pp. 1080-8 . https://doi.org/10.1016/0735-1097(93)90419-2
Europe PubMed Central
Journal of the American College of Cardiology, 22(4), 1080-1088. Elsevier USA
Verstraete, M, Nurmohamed, M, Kienast, J, Siebeck, M, Silling-Engelhardt, G, Büller, H, Hoet, B, Bichler, J & Close, P 1993, ' Biologic effects of recombinant hirudin (CGP 39393) in human volunteers. European Hirudin in Thrombosis Group ', Journal of the American College of Cardiology, vol. 22, no. 4, pp. 1080-8 . https://doi.org/10.1016/0735-1097(93)90419-2
Europe PubMed Central
Journal of the American College of Cardiology, 22(4), 1080-1088. Elsevier USA
OBJECTIVES: The purpose of this study was to investigate the biologic efficacy and pharmacokinetics of different doses of recombinant hirudin administered in single or repeated subcutaneous injections in healthy volunteers.BACKGROUND: Hirudin is a hi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4aa41dfede800a34413077a6b5ecdc37
https://research.vumc.nl/en/publications/be00fcc6-3e5e-4cd1-b0ca-e17690c41fb3
https://research.vumc.nl/en/publications/be00fcc6-3e5e-4cd1-b0ca-e17690c41fb3
Publikováno v:
Europe PubMed Central
The combination of thromboxane synthase inhibition with thromboxane receptor antagonism has been shown to result in a strong inhibition of platelet aggregation and a prolongation of the bleeding time (Gresele et al., J. Clin Invest 1987; 80: 1435-45)
Publikováno v:
Europe PubMed Central
Interference with blood platelet thromboxane A2 (TxA2)-formation using aspirin has proven to be clinically efficient in the prevention of arterial thrombosis. The protection, however, is far from absolute and during recent years we have witnessed the